Antiangiogenic agents targeting vascular endothelial growth factor and its receptors in clinical development-Reference-Cited by-同舟云学术

Antiangiogenic agents targeting vascular endothelial growth factor and its receptors in clinical development

Published:2002-10 Issue:10 Volume:11 Page:1447-1465
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Sepp-Lorenzino Laura¹,Thomas Kenneth A¹

Affiliation:

1. Department of Cancer Research, 770 Sumneytown Pike, Merck Research Laboratories, WP26-462, West Point, PA 19486, USA. laura_sepplorenzino@merck.com

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/13543784.11.10.1447

Reference112 articles.

1. Angiogenesis-dependent diseases

2. Transplacental Carcinogenesis by Stilbestrol

3. Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents

4. Vascular Endothelial Growth Factor, a Potent and Selective Angiogenic Agent

5. The Biology of Vascular Endothelial Growth Factor

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro Evaluation of Isatin derivatives as Potent Anti-Breast Cancer Agents against MCF-7, MDA MB 231, MDA-MB 435 and MDA-MB 468 Breast Cancers cell lines: A Review;Anti-Cancer Agents in Medicinal Chemistry;2021-09-03

2. Molecular modeling studies of quinoline derivatives as VEGFR-2 tyrosine kinase inhibitors using pharmacophore based 3D QSAR and docking approach;Arabian Journal of Chemistry;2017-05

3. 1,3,4-Oxadiazoles: An emerging scaffold to target growth factors, enzymes and kinases as anticancer agents;European Journal of Medicinal Chemistry;2015-06

4. Solution structure of the major G-quadruplex formed in the human VEGF promoter in K+: insights into loop interactions of the parallel G-quadruplexes;Nucleic Acids Research;2013-09-04

5. Design, synthesis and biological evaluation of new classes of thieno[3,2-d]pyrimidinone and thieno[1,2,3]triazine as inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2);European Journal of Medicinal Chemistry;2013-05